MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding MAIA Biotechnology, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 20 | 21 | +1 |
| Shares | 660.9K | 1.79M | +1.13M (+170.6%) |
| Value | $1.50M | $6.09M | +$4.59M (+305.5%) |
New holders (5)
Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Halter Ferguson Financial Inc. | 721,665 | $2.47M | 1.75% |
| Ground Swell Capital, LLC | 16,460 | $56.3K | 0.05% |
| Verition Fund Management LLC | 15,372 | $52.6K | 0.00% |
| Omers Administration Corp | 10,800 | $36.9K | 0.00% |
| Bank of America Corp | 137 | $469 | 0.00% |
Sold out (4)
Institutions that held MAIA Biotechnology, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 32,487 | $71.0K |
| Citadel Advisors LLC | 23,749 | $52.2K |
| Renaissance Technologies LLC | 19,000 | $42.0K |
| Wells Fargo & Company | 91 | $200 |